Figures & data
Figure 1. Weekly distribution of received and SARS-CoV-2 laboratory-confirmed specimens from Hospitals (green) and Primary Care Centres (brown). Lockdown and the different de-escalation phases are labelled in colours. Vaccine coverages from people living in Barcelona are represented by dot line (for one dose) and dash line (for two doses).
![Figure 1. Weekly distribution of received and SARS-CoV-2 laboratory-confirmed specimens from Hospitals (green) and Primary Care Centres (brown). Lockdown and the different de-escalation phases are labelled in colours. Vaccine coverages from people living in Barcelona are represented by dot line (for one dose) and dash line (for two doses).](/cms/asset/3d41d9ca-1a4d-459d-87c4-2ac715f7d2b7/temi_a_2011617_f0001_oc.jpg)
Table 1. Distribution of received and SARS-CoV-2 laboratory-confirmed specimens per origin, age group, and sex in each pandemic wave.
Figure 2. Weekly distribution of the different lineages during the study period (weeks 11/2020–24/2021) labelled in colours. Dashed line represents all SARS-CoV-2 laboratory-confirmed samples. Those prevalent lineages in each pandemic wave are blue squared.
![Figure 2. Weekly distribution of the different lineages during the study period (weeks 11/2020–24/2021) labelled in colours. Dashed line represents all SARS-CoV-2 laboratory-confirmed samples. Those prevalent lineages in each pandemic wave are blue squared.](/cms/asset/52c53383-1c31-4722-9df4-8a41ce3a99c0/temi_a_2011617_f0002_oc.jpg)
Table 2. Lineage observation overall, and per pandemic wave during the study period (% per pandemic wave).
Table 3. Evolutionary divergences on whole viral (29764 nt) and Spike (3822 nt) sequences within and between waves.